Gilead Sciences Currently Up Nine Consecutive Days, on Pace for Longest Winning Streak Since July 2023 — Data Talk
Gilead Sciences, Inc. (GILD) is currently at $79.29, up $0.73 or 0.93%
--Would be highest close since Jan. 26, 2024, when it closed at $79.52
--Currently up 12 of the past 13 days
--Currently up nine consecutive days; up 7.47% over this period
--Longest winning streak since July 21, 2023, when it rose for 10 straight trading days
--Best nine day stretch since the nine days ending July 29, 2024, when it rose 8.5%
--Up 4.25% month-to-date
--Down 2.12% year-to-date
--Down 35.12% from its all-time closing high of $122.21 on June 23, 2015
--Up 3.67% from 52 weeks ago (Aug. 31, 2023), when it closed at $76.48
--Down 9.16% from its 52-week closing high of $87.29 on Jan. 19, 2024
--Up 25.56% from its 52-week closing low of $63.15 on June 18, 2024
--Traded as high as $79.46; highest intraday level since Jan. 29, 2024, when it hit $80.00
--Up 1.15% at today's intraday high
All data as of 11:35:26 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 29, 2024 11:53 ET (15:53 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks